Sutro Biopharma, Inc. (STRO)

Last Closing Price: 8.50 (2026-11-18)

Profit Margin (Quarterly)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

Sutro Biopharma, Inc. (STRO) had Profit Margin of -346.11% for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$9.10M
$-31.49M
--
$9.10M
$31.05M
$-21.96M
$-9.53M
$-31.49M
$-31.49M
$-31.49M
$-31.49M
$-31.49M
$-31.49M
$-21.96M
$-21.01M
16.58M
16.58M
$-1.90
$-1.90
Balance Sheet Financials
$159.50M
$7.13M
$17.15M
$176.65M
$54.31M
--
$254.87M
$309.18M
$-132.54M
$-132.54M
$-132.54M
16.60M
Cash Flow Statement Financials
$-103.00M
$-11.07M
$102.79M
$58.99M
$47.71M
$-11.28M
$5.73M
--
--
Fundamental Metrics & Ratios
2.94
--
--
--
--
100.00%
-241.33%
-241.33%
--
-346.11%
Profit Margin
-346.11%
$-103.14M
--
--
--
0.05
--
0.71
126.77
23.76%
23.76%
-17.83%
23.76%
$-7.98
$-6.22
$-6.21